The pattern recognition module provides an execution environment for Three Line Strike recognition and related indicators on JIN MEDICAL. It emphasizes pattern recognition signals tied to momentum and continuation while keeping volatility, risk, and performance context in view.
The function did not generate any output. Please change time horizon or modify your input parameters. The output start index for this execution was eight with a total number of output elements of fifty-three. The function did not return any valid pattern recognition events for the selected time horizon. JIN MEDICAL INTERNATIONAL Three-Line Strike is one of pattern recognition indicators that helps to determine continuation of JIN MEDICAL trend.
JIN MEDICAL Technical Analysis Modules
Most technical analysis of JIN MEDICAL help investors determine whether a current trend will continue and, if not, when it will shift. We provide a combination of tools to recognize potential entry and exit points for JIN from various momentum indicators to cycle indicators. When you analyze JIN charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.
About JIN MEDICAL INTERNATIONAL LTD. Ordinary Shares
JIN MEDICAL is an entity of United States traded as a Stock on the NASDAQ Exchange exchange. The stock overview for JIN MEDICAL summarizes business drivers, financial profile, and market behavior. The company is positioned within Health Care Equipment & Supplies, Health Care Equipment & Services, Health Care. Current metrics include P/B of 0.75, profit margin of 5.76%. JIN MEDICAL has a market cap of 22.28 M, ROE of 4.75%.
Methodology
Unless otherwise specified, financial data for JIN MEDICAL INTERNATIONAL is derived from periodic company reporting (annual and quarterly where available). Asset-level metrics are computed daily by Macroaxis LLC and refreshed regularly based on asset type. JIN (USA Stocks:ZJYL) prices are typically delayed by approximately 20 minutes from primary exchanges for listed equities. Data may be delayed depending on reporting sources and market conventions. Assumptions: We primarily rely on public filings and market reference sources, including disclosures published by U.S. Securities and Exchange Commission (SEC) via EDGAR and the U.S. Food & Drug Administration (FDA). Data is normalized for analytical consistency across reporting formats. All analytics are generated using standardized, rules-based models designed to promote consistency and comparability across instruments. Model assumptions, reference parameters, and selected computational inputs are available in the Model Inputs section. If you have questions about our data sources or methodology, please contact Macroaxis Support.
Analyst Sources
JIN MEDICAL INTERNATIONAL may have analyst coverage included in Macroaxis-derived consensus inputs when available. Updates may occur throughout the day.
Using JIN MEDICAL INTERNATIONAL inside a theme workflow gives investors a structured way to compare related stocks, funds, ETFs, and crypto assets before allocating capital. The practical benefit is that the selected idea can be tuned either for higher upside or for tighter risk control.
Thematic Opportunities
Explore Investment Opportunities
Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked. Macroaxis thematic optimization helps investors identify companies most likely to benefit from changes or shifts in various micro-economic or local macro-level trends. Originating optimal thematic portfolios involves aligning investors' personal views, ideas, and beliefs with their actual investments.
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.
A structured review of JIN MEDICAL INTERNATIONAL often starts with core financial statements and trend context. Key ratios help frame profitability, efficiency, and growth context for JIN MEDICAL INTERNATIONAL Stock. Outlined below are key reports that provide context for JIN MEDICAL INTERNATIONAL Stock:
JIN MEDICAL has a market cap of 22.28 M, operating margin of 9.83%, ROE of 4.75%. Use Your Current Watchlist to explore allocation context. This includes a position in JIN MEDICAL INTERNATIONAL within the portfolio mix. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in unemployment.
Analysis related to JIN MEDICAL should be read together with other portfolio and risk tools before capital is reallocated. That is especially important when the goal is to improve the overall mix of instruments already held. You can also try the Transaction History module to view history of all your transactions and understand their impact on performance.
Quarterly Earnings Growth
-0.32
Earnings Share
0.01
Revenue Per Share
0.132
Quarterly Revenue Growth
-0.17
Return On Assets
0.0077
The market value of JIN MEDICAL INTERNATIONAL is measured differently than book value, which reflects JIN accounting equity. JIN MEDICAL's market capitalization is 22.28 M. A P/B ratio of 0.75 suggests JIN MEDICAL trades near or below book value. Enterprise value stands at 11.54 M. Intrinsic value represents an estimate of underlying worth and can differ from both market price and book value. Valuation methods compare these perspectives to frame context.
Note that JIN MEDICAL's intrinsic value and market price are different measures derived from different inputs. For JIN MEDICAL, key inputs include a P/B ratio of 0.75, a profit margin of 5.76%, ROE of 4.75%, and revenue of 20.69 M. By contrast, market price reflects the level where buyers and sellers transact.